Ad is loading...
VTPSX
Price
$129.64
Change
-$0.62 (-0.48%)
Updated
Nov 15 closing price
VTSNX
Price
$129.61
Change
-$0.62 (-0.48%)
Updated
Nov 15 closing price
Ad is loading...

VTPSX vs VTSNX

Header iconVTPSX vs VTSNX Comparison
Open Charts VTPSX vs VTSNXBanner chart's image
Vanguard Total Intl Stock Idx InstlPls
Price$129.64
Change-$0.62 (-0.48%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index I
Price$129.61
Change-$0.62 (-0.48%)
VolumeN/A
CapitalizationN/A
VTPSX vs VTSNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VTPSX vs. VTSNX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VTPSX is a Buy and VTSNX is a Buy.

FUNDAMENTALS
Fundamentals
VTPSX (442B) and VTSNX (442B) have equal amount of cash in the bank . VTPSX (3.30) and VTSNX (3.29) have matching dividends . VTPSX was incepted earlier than VTSNX: VTPSX (14 years) vs VTSNX (14 years). VTPSX (4.00) and VTSNX (4.00) have comparable annual turnover. VTSNX has a lower initial minimum investment than VTPSX: VTSNX (5000000) vs VTPSX (100000000). VTPSX (10.92) and VTSNX (10.92) have marching annual gain over last year. VTPSX (15.93) and VTSNX (15.91) have equivalent 5 years return.
VTPSXVTSNXVTPSX / VTSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years14 years-
Gain YTD4.5374.535100%
Front LoadN/AN/A-
Min. Initial Investment10000000050000002,000%
Min. Initial Investment IRAN/AN/A-
Net Assets442B442B100%
Annual Yield % from dividends3.303.29100%
Returns for 1 year10.9210.92100%
Returns for 3 years-5.85-5.86100%
Returns for 5 years15.9315.91100%
Returns for 10 years29.9229.81100%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLSK14.030.05
+0.36%
CleanSpark
BSRR31.33-0.19
-0.60%
Sierra Bancorp
GEHC81.76-1.16
-1.40%
GE HealthCare Technologies
NXTC1.31-0.03
-2.24%
NextCure
RCKT13.98-0.84
-5.67%
Rocket Pharmaceuticals